Skip to main content

Table 2 Univariate and multivariate analysis of prognostic factors for progression-free survival (PFS) and overall survival (OS) in advanced colorectal cancer

From: Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

 

PFS

OS

HR

95% CI

P

HR

95% CI

P

Univariate analysis

Gender

        

Male vs. Female

1.242

0.746

2.070

0.404

0.907

0.540

1.523

0.711

Age

        

<60 vs. ≥60

0.959

0.572

1.608

0.875

0.977

0.593

1.612

0.929

Tumor size

        

<5 vs. ≥5

1.173

0.708

1.944

0.535

0.766

0.465

1.259

0.293

Location

        

Colon vs. Rectum

0.945

0.564

1.584

0.831

1.331

0.809

2.190

0.261

Differentiation

        

Well vs. Middle vs. Poor

0.746

0.521

1.068

0.109

1.000

0.696

1.437

0.999

T

        

T1+T2 vs. T3 vs. T4a vs. T4b

1.164

.871

1.555

0.304

1.081

.810

1.442

0.597

N

        

N0 vs. N1 vs. N2a vs. N2b

1.255

1.009

1.562

0.042*

1.507

1.210

1.875

<0.001***

TNM

        

II+III vs. IVa vs. IVb

2.027

1.383

2.971

<0.001***

1.552

1.091

2.207

0.015*

CEA (ng/ml)

        

≤10 vs. >10

1.828

1.070

3.121

0.027*

1.452

0.884

2.385

0.141

CA199 (U/ml)

≤37 vs. >37

1.620

0.973

2.698

0.064

1.123

0.684

1.842

0.647

CTCs

        

Negative vs. Positive

2.870

1.716

4.801

<0.0001***

1.664

1.003

2.761

0.048*

Multivariate analysis

N

        

N0 vs. N1 vs. N2a vs. N2b

1.169

0.930

1.469

0.180

1.499

1.198

1.876

<0.001***

TNM

        

II + III vs. IVa vs. IVb

1.687

1.115

2.553

0.013*

1.580

1.086

2.298

0.017*

CEA (ng/ml)

        

≤10 vs. >10

1.258

0.712

2.224

0.429

    

CTCs

        

Negative vs. Positive

1.993

1.141

3.483

0.015*

1.148

0.679

1.943

0.606

  1. Italic values indicate statistically significant associations
  2. * P < 0.05, *** P < 0.001